[HTML][HTML] Prevalence of SARS-CoV-2 antibodies in first responders and public safety personnel, New York City, New York, USA, May–July 2020

S Sami, LJ Akinbami, LR Petersen… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We conducted a serologic survey in public service agencies in New York City, New York,
USA, during May–July 2020 to determine prevalence of severe acute respiratory syndrome …

[HTML][HTML] SARS-CoV-2 seroprevalence among healthcare, first response, and public safety personnel, Detroit metropolitan area, Michigan, USA, May–June 2020

LJ Akinbami, N Vuong, LR Petersen… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
To estimate seroprevalence of severe acute respiratory syndrome 2 (SARS-CoV-2) among
healthcare, first response, and public safety personnel, antibody testing was conducted in …

Seroprevalence of severe acute respiratory syndrome coronavirus 2 following the largest initial epidemic wave in the United States: findings from New York City, 13 …

P Pathela, A Crawley, D Weiss, B Maldin… - The Journal of …, 2021 - academic.oup.com
Abstract Background New York City (NYC) was the US epicenter of the spring 2020
coronavirus disease 2019 (COVID-19) pandemic. We present the seroprevalence of severe …

SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study

M Brant-Zawadzki, D Fridman, PA Robinson, M Zahn… - PLoS …, 2020 - journals.plos.org
Serological surveys have been conducted to establish prevalence for COVID-19 antibodies
in various cohorts and communities, reporting a wide range of outcomes. The prevalence of …

Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020

P Pathela, A Crawley, D Weiss, B Maldin… - The Journal of …, 2021 - stacks.cdc.gov
Abstract Background New York City (NYC) was the US epicenter of the Spring 2020 COVID-
19 pandemic. We present seroprevalence of SARS-CoV-2 infection and correlates of …

Prevalence of SARS-CoV-2 antibodies in New York City adults, June–October 2020: a population-based survey

JC Parrott, AN Maleki, VE Vassor… - The Journal of …, 2021 - academic.oup.com
Background Serosurveys help to ascertain burden of infection. Prior severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) serosurveys in New York City (NYC) used …

Seroprevalence of SARS-CoV-2-specific IgG antibodies among adults living in Connecticut: Post-infection prevalence (PIP) study

S Mahajan, R Srinivasan, CA Redlich… - The American journal of …, 2021 - Elsevier
Background A seroprevalence study can estimate the percentage of people with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the general …

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

KN Althoff, DJ Schlueter, H Anton-Culver… - Clinical Infectious …, 2022 - academic.oup.com
Background With limited severe acute respiratory syndrome coronavirus (SARS-CoV-2)
testing capacity in the United States at the start of the epidemic (January–March 2020) …

Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19

M Psichogiou, A Karabinis, ID Pavlopoulou… - PLoS …, 2020 - journals.plos.org
Introduction Greece is a country with limited spread of SARS-CoV-2 and cumulative infection
attack rate of 0.12%(95% CI 0.06–0.26). Health care workers (HCWs) are a well-recognized …

Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut

P Papasavas, S Olugbile, U Wu, K Robinson… - Journal of Hospital …, 2021 - Elsevier
Summary Background Healthcare workers (HCWs) are at the front line of the ongoing
coronavirus 2019 (COVID-19) pandemic. Comprehensive evaluation of the seroprevalence …